Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.

Díaz-Tocados JM, Rodríguez-Ortiz ME, Almadén Y, Pineda C, Martínez-Moreno JM, Herencia C, Vergara N, Pendón-Ruiz de Mier MV, Santamaría R, Rodelo-Haad C, Casado-Díaz A, Lorenzo V, Carvalho C, Frazão JM, Felsenfeld AJ, Richards WG, Aguilera-Tejero E, Rodríguez M, López I, Muñoz-Castañeda JR.

Kidney Int. 2019 May;95(5):1064-1078. doi: 10.1016/j.kint.2018.12.015. Epub 2019 Mar 12.

2.

Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.

Felsenfeld AJ, Levine BS, Rodriguez M.

Semin Dial. 2015 Nov-Dec;28(6):564-77. doi: 10.1111/sdi.12411. Epub 2015 Aug 25. Review.

PMID:
26303319
3.

Metabolic acidosis-induced hypercalcemia in an azotemic patient with primary hyperparathyroidism.

Rastegar M, Levine BS, Felsenfeld AJ.

Clin Kidney J. 2014 Jun;7(3):299-302. doi: 10.1093/ckj/sfu041. Epub 2014 May 9.

4.

Calcitonin, the forgotten hormone: does it deserve to be forgotten?

Felsenfeld AJ, Levine BS.

Clin Kidney J. 2015 Apr;8(2):180-7. doi: 10.1093/ckj/sfv011. Epub 2015 Mar 20.

5.

Serum calcium and bone: effect of PTH, phosphate, vitamin D and uremia.

Levine BS, Rodríguez M, Felsenfeld AJ.

Nefrologia. 2014;34(5):658-69. doi: 10.3265/Nefrologia.pre2014.Jun.12379. Review. English, Spanish.

6.

Approach to treatment of hypophosphatemia.

Felsenfeld AJ, Levine BS.

Am J Kidney Dis. 2012 Oct;60(4):655-61. doi: 10.1053/j.ajkd.2012.03.024. Epub 2012 Aug 3. Review.

PMID:
22863286
7.

An unusual case of hyperphosphatemia in a vitamin D-deficient patient with tuberculosis.

Lee RH, Felsenfeld AJ, Levine BS.

NDT Plus. 2011 Aug;4(4):264-9. doi: 10.1093/ndtplus/sfr029. Epub 2011 Apr 27. No abstract available.

8.

Fuller Albright and our current understanding of calcium and phosphorus regulation and primary hyperparathyroidism.

Felsenfeld AJ, Levine BS, Kleeman CR.

Nefrologia. 2011;31(3):346-57. doi: 10.3265/Nefrologia.pre2011.Mar.10774. Review.

9.

Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.

Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.

Nephrol Dial Transplant. 2010 Apr;25(4):1087-97. doi: 10.1093/ndt/gfp616. Epub 2009 Nov 23.

PMID:
19934096
10.

Fuller albright: the consummate clinical investigator.

Kleeman CR, Levine BS, Felsenfeld AJ.

Clin J Am Soc Nephrol. 2009 Oct;4(10):1541-6. doi: 10.2215/CJN.03030509. Epub 2009 Sep 24. No abstract available.

11.

The journey from vitamin D-resistant rickets to the regulation of renal phosphate transport.

Levine BS, Kleeman CR, Felsenfeld AJ.

Clin J Am Soc Nephrol. 2009 Nov;4(11):1866-77. doi: 10.2215/CJN.03000509. Epub 2009 Oct 1. Review.

12.

PTH, FGF-23 and early CKD.

Rodriguez M, Felsenfeld AJ.

Nephrol Dial Transplant. 2008 Nov;23(11):3391-3. doi: 10.1093/ndt/gfn438. Epub 2008 Jul 31. No abstract available.

PMID:
18676347
13.

Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.

Felsenfeld AJ, Rodríguez M, Aguilera-Tejero E.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1283-305. Epub 2007 Oct 17. Review.

14.

Milk alkali syndrome and the dynamics of calcium homeostasis.

Felsenfeld AJ, Levine BS.

Clin J Am Soc Nephrol. 2006 Jul;1(4):641-54. Epub 2006 Apr 26. Review. No abstract available.

15.

Effect of changes in ionized calcium concentration in arterial blood and metabolic acidosis on the arterial partial pressure of oxygen in dogs.

Lopez I, Felsenfeld AJ, Estepa JC, Rodriguez M, Aguilera-Tejero E.

Am J Vet Res. 2006 May;67(5):801-8.

PMID:
16649913
16.

Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats.

Jara A, von Höveling A, Jara X, Burgos ME, Valdivieso A, Mezzano S, Felsenfeld AJ.

Nephrol Dial Transplant. 2006 Apr;21(4):917-23. Epub 2006 Jan 23.

PMID:
16431896
17.

Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes.

Jara A, Chacón C, Ibaceta M, Valdivieso A, Felsenfeld AJ.

Nephrol Dial Transplant. 2004 Aug;19(8):1986-92. Epub 2004 Jun 1.

PMID:
15173378
18.

Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. Part II--Kidney hypertrophy and calcium deposition.

Jara A, Chacón C, Ibaceta M, Valdivieso A, Felsenfeld AJ.

Nephrol Dial Transplant. 2004 Aug;19(8):1993-8. Epub 2004 May 25.

PMID:
15161952
19.

Role of acidosis-induced increases in calcium on PTH secretion in acute metabolic and respiratory acidosis in the dog.

López I, Aguilera-Tejero E, Estepa JC, Rodríguez M, Felsenfeld AJ.

Am J Physiol Endocrinol Metab. 2004 May;286(5):E780-5. Epub 2004 Jan 13.

20.

Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender.

Almaden Y, Felsenfeld AJ, Rodriguez M, Cañadillas S, Luque F, Bas A, Bravo J, Torregrosa V, Palma A, Ramos B, Sanchez C, Martin-Malo A, Canalejo A.

Kidney Int. 2003 Dec;64(6):2311-7.

21.

Direct suppressive effect of acute metabolic and respiratory alkalosis on parathyroid hormone secretion in the dog.

Lopez I, Rodriguez M, Felsenfeld AJ, Estepa JC, Aguilera-Tejero E.

J Bone Miner Res. 2003 Aug;18(8):1478-85.

22.

Dynamics of secretion and metabolism of PTH during hypo- and hypercalcaemia in the dog as determined by the 'intact' and 'whole' PTH assays.

Estepa JC, Lopez I, Felsenfeld AJ, Gao P, Cantor T, Rodríguez M, Aguilera-Tejero E.

Nephrol Dial Transplant. 2003 Jun;18(6):1101-7.

PMID:
12748341
24.

Direct effect of acute metabolic and respiratory acidosis on parathyroid hormone secretion in the dog.

Lopez I, Aguilera-Tejero E, Felsenfeld AJ, Estepa JC, Rodriguez M.

J Bone Miner Res. 2002 Sep;17(9):1691-700.

25.

How dietary phosphate, renal failure and calcitriol administration affect the serum calcium-phosphate relationship in the rat.

Jara A, Chacón C, Felsenfeld AJ.

Nephrol Dial Transplant. 2002 May;17(5):765-71.

PMID:
11981061
26.

Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.

Jara A, Chacón C, Valdivieso A, Aris L, Jalil R, Felsenfeld AJ.

Nephrol Dial Transplant. 2001 May;16(5):1009-16.

PMID:
11328908
27.

Failure of high doses of calcitriol and hypercalcaemia to induce apoptosis in hyperplastic parathyroid glands of azotaemic rats.

Jara A, González S, Felsenfeld AJ, Chacón C, Valdivieso A, Jalil R, Chuaqui B.

Nephrol Dial Transplant. 2001 Mar;16(3):506-12.

PMID:
11239023
28.

The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis.

Canalejo A, Almadén Y, Torregrosa V, Gomez-Villamandos JC, Ramos B, Campistol JM, Felsenfeld AJ, Rodríguez M.

J Am Soc Nephrol. 2000 Oct;11(10):1865-72.

29.

Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease.

Jara A, Felsenfeld AJ, Bover J, Kleeman CR.

Kidney Int. 2000 Sep;58(3):1023-32.

30.
31.

Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis.

Holgado R, Haire H, Ross D, Sprague S, Pahl M, Jara A, Martin-Malo A, Rodriguez M, Almaden Y, Felsenfeld AJ.

J Bone Miner Res. 2000 May;15(5):927-35.

32.

Effect of phosphate on parathyroid hormone secretion in vivo.

Estepa JC, Aguilera-Tejero E, Lopez I, Almaden Y, Rodriguez M, Felsenfeld AJ.

J Bone Miner Res. 1999 Nov;14(11):1848-54.

33.
34.

Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus.

Bover J, Jara A, Trinidad P, Rodriguez M, Felsenfeld AJ.

Bone. 1999 Sep;25(3):279-85.

PMID:
10495131
35.

Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients.

Borrego MJ, Martin-Malo A, Almaden Y, Rodriguez M, Aljama P, Felsenfeld AJ.

Am J Kidney Dis. 1999 Sep;34(3):456-63.

PMID:
10469855
36.

Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.

Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Lorenzo V, Cubero J, Martin-Malo A, Betriu A, Jimenez A, Torres A, Felsenfeld AJ.

Kidney Int. 1999 Jul;56(1):306-17.

37.

Effect of rate of calcium reduction and a hypocalcemic clamp on parathyroid hormone secretion: a study in dogs.

Estepa JC, Aguilera-Tejero E, Almaden Y, Rodriguez M, Felsenfeld AJ.

Kidney Int. 1999 May;55(5):1724-33.

38.

Bone, parathyroid hormone and the response to the rapid induction of hypocalcaemia.

Felsenfeld AJ.

Eur J Clin Invest. 1999 Apr;29(4):274-7. No abstract available.

PMID:
10231337
39.

Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: a hypothesis to integrate a historical and modern perspective.

Felsenfeld AJ, Rodriguez M.

J Am Soc Nephrol. 1999 Apr;10(4):878-90. Review. No abstract available.

40.

Phosphate depletion in the rat: effect of bisphosphonates and the calcemic response to PTH.

Jara A, Lee E, Stauber D, Moatamed F, Felsenfeld AJ, Kleeman CR.

Kidney Int. 1999 Apr;55(4):1434-43.

41.

Measurement of parathyroid hormone in horses.

Estepa JC, Aguilera-Tejero E, Mayer-Valor R, Almadén Y, Felsenfeld AJ, Rodríguez M.

Equine Vet J. 1998 Nov;30(6):476-81.

PMID:
9844965
42.

Mineral metabolism in healthy geriatric dogs.

Aguilera-Tejero E, López I, Estepa JC, Mayer-Valor R, Almadén Y, Concepción MT, Felsenfeld AJ, Rodriguez M.

Res Vet Sci. 1998 May-Jun;64(3):191-4.

PMID:
9690601
43.

Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure.

Frazão JM, Elangovan L, Felsenfeld AJ, Stanley TM, Cohen AH.

Nephrol Dial Transplant. 1998 Jul;13(7):1849-52. No abstract available.

PMID:
9681746
44.

The PTH-calcium relationship during a range of infused PTH doses in the parathyroidectomized rat.

Berdud I, Martin-Malo A, Almaden Y, Aljama P, Rodriguez M, Felsenfeld AJ.

Calcif Tissue Int. 1998 May;62(5):457-61.

PMID:
9541525
45.

Impact of the method of calculation on assessment of the parathyroid hormone-calcium set point.

Felsenfeld AJ, Rodriguez M.

Nephrol Dial Transplant. 1997 Aug;12(8):1768-9. No abstract available.

PMID:
9269674
46.

Considerations for the treatment of secondary hyperparathyroidism in renal failure.

Felsenfeld AJ.

J Am Soc Nephrol. 1997 Jun;8(6):993-1004. Review. No abstract available.

47.

Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism.

Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Lorenzo V, Cubero J, Martin-Malo A, Betriu A, Rodriguez AP, Felsenfeld AJ.

J Bone Miner Res. 1997 Mar;12(3):347-55.

48.

Evidence for adaptation of the entire PTH-calcium curve to sustained changes in the serum calcium in haemodialysis patients.

Borrego MJ, Felsenfeld AJ, Martin-Malo A, Almaden Y, Concepción MT, Aljama P, Rodriguez M.

Nephrol Dial Transplant. 1997 Mar;12(3):505-13.

PMID:
9075132
49.

A reduced PTH response to hypocalcemia after a short period of hypercalcemia: a study in dogs.

Sánchez J, Aguilera-Tejero E, Estepa JC, Almadén Y, Rodríguez M, Felsenfeld AJ.

Kidney Int Suppl. 1996 Dec;57:S18-22.

PMID:
8941917
50.

The set point of calcium--another view.

Felsenfeld AJ, Rodriguez M.

Nephrol Dial Transplant. 1996 Sep;11(9):1722-5. No abstract available.

PMID:
8918610

Supplemental Content

Loading ...
Support Center